155 results
Categories
Human Remove Human filter
Patient safety
Yes Remove Yes filter
-
List item
News: EMA confirms measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders (updated)
CHMP, Last updated: 13/01/2023 -
List item
News: EMA recommends withdrawal of pholcodine medicines from EU market
PRAC, Last updated: 02/12/2022 -
List item
News: EMA recommends measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders
PRAC, Last updated: 03/11/2022 -
List item
News: EMA confirms recommendation to withdraw marketing authorisations for amfepramone medicines
PRAC, Last updated: 28/10/2022 -
List item
News: New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome
PRAC, Last updated: 30/09/2022 -
List item
News: Review of pholcodine medicines started
PRAC, Last updated: 02/09/2022 -
List item
News: PRAC starts review of topiramate use in pregnancy and women of childbearing potential
PRAC, Last updated: 02/09/2022 -
List item
News: Hydroxyethyl-starch solutions for infusion recommended for suspension from the market
CMDh, Last updated: 26/07/2022 -
List item
News: EMA recommends restricting use of cancer medicine Rubraca
CHMP, Last updated: 22/07/2022 -
List item
News: EMA recommends withdrawal of marketing authorisation for amfepramone medicines
PRAC, Last updated: 10/06/2022 -
List item
News: Synchron Research Service: suspension of medicines over flawed studies
CHMP, Last updated: 20/05/2022 -
List item
News: COVID-19: latest safety data provide reassurance about use of mRNA vaccines during pregnancy
CHMP, PRAC, Last updated: 18/01/2022 -
List item
News: CHMP endorses review finding no link between viral vector in Zynteglo and blood cancer
CAT, CHMP, Last updated: 23/07/2021 -
List item
News: COVID-19 Vaccine Janssen: Guillain-Barré syndrome listed as a very rare side effect
PRAC, Last updated: 22/07/2021 -
List item
News: Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis
PRAC, Last updated: 09/07/2021 -
List item
News: EMA advises against use of COVID-19 Vaccine Janssen in people with history of capillary leak syndrome
PRAC, Last updated: 09/07/2021 -
List item
News: COVID-19 vaccines: update on ongoing evaluation of myocarditis and pericarditis
PRAC, Last updated: 11/06/2021 -
List item
News: Vaxzevria: EMA advises against use in people with history of capillary leak syndrome
PRAC, Last updated: 11/06/2021 -
List item
News: EMA raises awareness of clinical care recommendations to manage suspected thrombosis with thrombocytopenia syndrome
Last updated: 07/06/2021 -
List item
News: Vaxzevria: further advice on blood clots and low blood platelets
CHMP, Last updated: 21/05/2021 -
List item
News: AstraZeneca’s COVID-19 vaccine: benefits and risks in context
CHMP, Last updated: 23/04/2021 -
List item
News: COVID-19 Vaccine Janssen: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets
PRAC, Last updated: 20/04/2021 -
List item
News: AstraZeneca’s COVID-19 vaccine: EMA to provide further context on risk of very rare blood clots with low blood platelets
CHMP, Last updated: 14/04/2021 -
List item
News: COVID-19 Vaccine Janssen: assessment of very rare cases of unusual blood clots with low platelets continues
PRAC, Last updated: 14/04/2021 -
List item
News: AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets
PRAC, Last updated: 07/04/2021